TRU

What Wall St. Knows About TransUnion Today.

Shares of TransUnion have moved 3.4% today, and are now trading at a price of $70.19. In contrast, the S&P 500 index saw a 1.4% change. Today's trading volume is 584,827 compared to the stock's average volume of 1,539,867.

TransUnion provides risk and information solutions. Based in Chicago, United States the company has 10,200 full time employees and a market cap of $13,525,613,568. TransUnion currently offers its equity investors a dividend that yields 0.6% per year.

The company is now trading -7.46% away from its average analyst target price of $75.85 per share. The 17 analysts following the stock have set target prices ranging from $62 to $100, and on average give TransUnion a rating of buy.

Over the last year, TRU shares have gone down by -33.9%, which represents a difference of -24.0% when compared to the S&P 500. The stock's 52 week high is $105.23 per share and its 52 week low is $50.32. With its increasingly high debt levels, TransUnion may not have a strong enough business to reverse this trend despite its strong EPS growth.

2019-12-31 2020-12-31 2021-12-31
Revenue (MM) $2,656 $2,717 $2,960
Revenue Growth n/a 2.28% 8.97%
Gross Margins 67.1% 66.1% 66.5%
Gross Margins Growth n/a -1.49% 0.61%
Operating Margins 22.9% 20.9% 21.9%
Operating Margins Growth n/a -8.73% 4.78%
Earnings Per Share $1.81 $1.79 $7.19
EPS Growth n/a -1.1% 301.68%
Free Cash Flow (MM) $578 $573 $584
FCF Growth n/a -0.85% 1.88%
Capital Expenditures (MM) -$198 -$214 -$224
Net Debt / EBITDA 3.48 3.11 4.39
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS